Abstract: This invention relates to a safety needle accessory scaled within a pack suitable for sealing pre-filled syringes. The safety needle accessory comprises a hub (7) for surrounding a hollow needle (4) having a tip and having a connector for attachment to a syringe, a slidable sleeve (8) adapted to slide over the needle in a first longitudinal direction from a first position in which the needle is fully or partially covered by the sleeve to a second position in which the needle is exposed, and in a second longitudinal direction from the second position to a third position in which the needle is fully covered by the sleeve, and a pack (9) surrounding the hollow needle, hub and slidable sleeve having a closed end covering the needle and an open end exposing the connector of the hub. The safety needle accessory further comprises a first seal (10) attached to the connector of the hub and a second seal (11) between the hub and the pack.
Safety needle accessory
This invention relates to a safety needle accessory and particularly to a safety needle accessory sealed with in a pack suitable for sealing pre-filled syringes.
Needle stick injuries carry a significant risk of spreading infection such as HIV and hepatitis, and are commonplace among healthcare workers. The USA has led the way in introducing legislation that obliges healthcare providers to use the safest devices when giving injections, intravenous drug administration and similar invasive procedures. Other countries are following, and even without legislation, the ever-present risk of litigation has alerted pharmaceutical companies and health authorities to seek suitable safe devices.
As a result of the heightened awareness of needle stick injuries, there have been a large number of inventions purporting to solve the problem. Most take the form of a protective sleeve which covers the needle tip after the injection has been given, or means for retracting the needle rapidly into the syringe barrel. In the former case, a weakness of the designs has been the need for the user to perform an action to render the needle safe; thus if the step is omitted, the risk remains. In the second case, the needle retraction mechanism requires that the syringe plunger is pushed to the end of its stroke in order to activate the retraction mechanism. In other words, virtually none of the devices are "fail safe", hi many real-life situations, the patient can involuntarily react to the pain of the injection and pull away from the needle, exposing the sharp tip, and therefore presenting a risk of a needle stick.
Another drawback of prior art safety needles (which hi the present context includes safety syringes) is that they are not compatible with current accepted practice. The problems includes drug incompatibility with the device construction materials, difficulty in using standard sterilising methods, difficulty in fitting to the syringe, large size, difficulty in filling, and very high cost.
A common requirement is for pre-filled syringes, and for reasons of drug compatibility and long-term storage, the syringe barrel is often made from glass, with the hypodermic needle bonded into the delivery end of the syringe barrel.
Alternatively, a few drugs are compatible with plastics, and there are available plastic syringe barrels with moulded or bonded hypodermic needles. Hitherto, there have not been any successful combinations of pre-filled syringe with a bonded-in needle and a safety device to protect the user from suffering a needle-stick injury, and it is to this requirement the present invention is directed. One of the main reasons for the lack of commercial success is that the proposed new devices often include drug contact materials which do not have a safety and compatibility record, or have clumsy operating procedure, are too big, or incompatible with common filling techniques and so forth.
As stated hereinabove, there have been no successful safety needle and pre-filled syringe combinations, and the challenge is to meet the strict requirements of various sterilising methods, maintaining sterility of the drug and needle during storage, preventing loss of drug through thermal expansion, ease of use, and low cost.
Accordingly, the present invention provides a safety needle accessory comprising a hub for surrounding a hollow needle having a tip and having a connector for attachment to a syringe, a slidable sleeve adapted to slide over the needle in a first longitudinal direction from a first position in which the needle is fully or partially covered by the sleeve to a second position in which the needle is exposed, and in a second longitudinal direction from the second position to a third position in which the needle is fully covered by the sleeve, and a pack surrounding the hollow needle, hub and slidable sleeve having a closed end covering the needle and an open end exposing the connector of the hub, wherein the safety needle accessory further comprises a first seal attached to the connector of the hub and a second seal between the hub and the pack.
The present invention also provides an injection device comprising a syringe having a hollow needle attached thereto and a safety needle accessory as defined herein.
In a first preferred embodiment, a safety device as described in our co-pending patent application WO 2004/071560 is assembled to a syringe (i.e. barrel and plunger) having a bonded hypodermic needle, over which is fitted the safety device. A seal between the syringe and hub of the safety needle accessory is provided by a soft
polymer. A pack encloses the syringe and safety device assembly, and has a rubber seal which seals against the periphery of the safety device hub, and further has a rubber seal which seals the opening of the hypodermic needle.
In a second preferred embodiment, which is similar to the first, the seal between the hub of the safety needle accessory and connector also seals directly to the pack, and the hypodermic needle seal is provided as before.
As an alternative to the previous embodiments, in a third embodiment, the safety device is bonded to the outlet connector of a syringe.
The present invention will now described with reference to the following drawings, in
which:
Fig. 1 shows a longitudinal section on the centreline of a syringe and safety needle
accessory in accordance with an embodiment of the present invention;
Figs. 2 and 3 show an overall view of the syringe and safety needle accessory in
accordance with the present invention with the pack attached and detached,
respectively;
Fig. 4 shows a longitudinal section on the centreline of a syringe and safety needle
accessory in accordance with a further embodiment of the present invention; and
Fig. 5 shows a similar assembly to those illustrated in the other drawings in which the
safety device is bonded to the syringe with an adhesive.
Unless stated otherwise, like parts are given like notation.
Fig. 1 shows an injection device A having a syringe 1 (only part of the syringe barrel is shown) having a connector 2. Connector 2 has a hole 3, into which is bonded with an adhesive 5 a hollow needle 4 permitting fluid communication between the syringe and the hollow needle 4. The syringe is often made from borosilicate glass, and the stainless steel needle may be bonded with an ultra-violet cured adhesive, this being a typical construction in common use. The safety needle accessory 6, which is more fully described in WO 2004/071560, has a hub 7 which surrounds the connector 2, and is fitted with slidable sleeve 8, although any other safety shield could be used. The sleeve 8 is arranged to operate when the needle device is pushed onto the patient's
skin, by sliding along the hub in the direction of arrow X. When the device is withdrawn from the patient, the sleeve 8 slides back down the hub 7 until it locks in a position to prevent a needle stick injury. There are a number of devices which have been disclosed which achieve the same objective of preventing needle stick injuries, and the present invention may be adapted to suit the features peculiar to those devices, to achieve the same end.
In the present invention, the hub 7 has a hole 14 through which the needle 4 passes with clearance. Hub 7 has an elastic seal 10 which engages sealingly with the connector 2. The connector 2 has a ridge 13 around its circumference, which locally increases the sealing force on the seal 10, and preferably prevents easy removal of the hub 7 and seal 10 from the connector 2. Thus, the elasticity of the seal provides frictional contact between the seal and the other component (here the connector on the syringe) such that a barrier to the ingress of bacteria and pyrogens is created. To achieve low manufacturing cost, the hub 7 may be made from a plastics material, and seal 10 is preferably co-injected moulded into the hub 7. This process will ensure bonding of the seal 10 to the hub 7, and thus prevent the passage of harmful bacteria at the junction. Alternatively, and not shown, the seal 10 may be moulded as a separate component, and may feature suitable ribs to engage the hub 7. To complete the protection of the drug and needle, a pack 9 is fitted over the safety device/syringe assembly. The pack 9 has an elastic seal 11 which seals onto the rim 15 of seal 10. In addition, a third seal 12 may be located in the closed end of the pack 9, i.e. the end distal to the syringe, and seals the tip of the needle 4. The third seal 12 is typically an elastic seal and sealing is effected by the needle being position such that the tip penetrates the seal 12. The third seal prevents loss or contamination of the injectate. Preferably, the pack 9 has one or more holes 16 sealed by the elastic seal 12, but through which sterilising gas may permeate. Seal 12 prevents the contents of the .syringe 1 from leaking during thermal expansion. The pack 9 is preferably moulded in an inexpensive pharmaceutical grade of polyethylene or polypropylene, and the two seals 11 and 12 are preferably co-injection moulded to the pack 9. Alternatively, and not shown, both seals 11 and 12 may be made as separate components with the necessary ribs and retaining features to ensure sealing and retention when fitted to the pack 9.
The seal material for the first or second seal 10 and 11 may be low-density polyethylene or a rubber, and the third seal 12 is preferably a pharmaceutical grade of. sealing rubber such as iso-butyl rubber. This material is often used because it is a gas-permeable material which permits the passage of a sterilising gas, such as ethylene oxide, but prevents the passage of harmful bacteria and pyrogens. A common way of bulk packing syringes for pre-filling is to load them into holes in a plastic tray, so that the syringes hang by the finger flange. The loaded tray is placed into a plastic tub, and sealed by a permeable membrane. The sealed tub is subjected to a sterilising gas such as ethylene oxide, and then, after a period, ordinary atmosphere permeates through the membrane to displace the sterilising gas, and the membrane prevents the passage of bacteria. During this process, the sterilising gas also permeates through the rubber seals that protect the needle.
When it is preferable to avoid using ethylene oxide or other sterilising gas sterilise the assembly, other techniques such as by gamma radiation may be used, and since the sealing materials are not required to be permeable, may be made from other resilient or conformable materials, such as polyester elastomers.
The assembly is shown complete in Fig. 2, and in use, the pack 9 is withdrawn from the syringe/safety needle assembly, Fig. 3, and the injection is given. By incorporating the first and second seals 10 and 11, the ingress of contaminants into the pack 9 is prevented. The first seal 10 provides a seal between the connectors of the syringe 1 and hub 7 when the syringe is attached. The second seal 11 provides a seal between the hub 7 and the interior rim 15 of the open end of the pack 9 when the pack is positioned over the hub 7.
Fig. 4 shows a very similar assembly, but in this case, the first and second seals 10 and 11 are formed of a unitary structure 10' which also seals on the inside of the pack 9, thus reducing the cost of the seals, and reducing the number of potential leakage paths. As an alternative to a unitary structure, the first and second seals are formed separately but are in mutual contact.
Where the accessory is supplied separately from the syringe, the open end of the pack may be covered by a releasable membrane or cap.
Fig. 5 shows yet another alternative method of sealing the hub 7 to the connector 2 by an adhesive 17. Thus, in this embodiment the first seal 10 is an adhesive 17. The adhesive may be coated on the hub 7 and adheres to the syringe when the syringe connector is engaged with the hub connector. Preferably, the injection device is supplied with a pre-filled syringe adhered to the safety needle accessory. A suitable adhesive would be UV-cured or other rapidly setting adhesive compatible with the materials of construction.
The present invention is compatible with current pre-filled syringe technology, including pre-filled reconstitution syringes, whereby a solvent is caused to mix with a lyophilised drug prior to administration.
In all embodiments, when the pack 9 is removed, the safety device remains on the syringe. The present invention is not limited to a precise mechanism of operation of the slidable sleeve. However, the slidable sleeve adapted to slide over the needle in a first longitudinal direction from a first position in which the needle is fully or partially covered by the sleeve to a second position in which the needle is exposed, and in a second longitudinal direction from the second position to a third position in which the needle is fully covered by the sleeve. Preferably the slidable sleeve has an elastically deformable portion and/or further comprises an elastically deformable member such that as the slidable sleeve is caused to move in the first direction towards the second position as the needle is injected into a patient, a resultant force is generated in the deformable portion or deformable member which causes the slidable sleeve to move towards the third (and first) position when the needle is removed from the patient, the safety needle accessory further comprising a locking mechanism capable of retaining the slidable sleeve in the third position after removal of the needle from the patient. The accessory may also further comprise engageable portions on the slidable sleeve and the hub to hold the sleeve in the first position where the sleeve is partially retracted and, when assembled with a syringe having a hollow needle, the needle is partially exposed. This allows the tip of the needle to be seen by the user prior to injection. This assists the user in guiding the needle for placement on the patient's skin or .aspirating excess drug or air. Preferably the injection device of the present invention is supplied prior to use with the needle tip partially exposed. The pack is
then removed and the needle injected into the patient. Further details are described in WO 2004/071560. Other safety devices intended to prevent or reduce needle-stick injuries, and which may employ a resiliently biased sliding sleeve (see, for example US 4,813,940 and US 5,104,384) may also be used with the accessory of the present invention.
Claims
1. A safety needle accessory comprising
a hub for surrounding a hollow needle having a tip and having a connector for
attachment to a syringe,
a slidable sleeve adapted to slide over the needle in a first longitudinal direction from
a first position in which the needle is fully or partially covered by the sleeve to a
second position in which the needle is exposed, and in a second longitudinal direction
from the second position to a third position in which the needle is fully covered by the
sleeve,
and a pack surrounding the hollow needle, hub and slidable sleeve having a closed
end covering the needle and an open end exposing the connector of the hub,
wherein the safety needle accessory further comprises a first seal attached to the
connector of the hub and a second seal between the hub and the pack.
2. A safety needle accessory as claimed in claim 1, wherein the first seal is an
elastic seal.
3. A safety needle accessory as claimed in any preceding claim, wherein the
second seal is an elastic seal.
4. A safety needle accessory as claimed in any preceding claim, wherein the
safety syringe further comprises a third seal between the closed end of the pack and
the needle tip.
5. A safety needle accessory as claimed in claim 4, wherein the third seal is an
elastic seal.
6. A safety needle accessory as claimed in claims 4 or 5, wherein the closed end
of the pack contains one or more holes and the third seal is composed of a gas-
permeable material.
7. A safety needle accessory as claimed in claim 6, wherein the gas-permeable
material is an iso-butyl rubber.
8. A safety needle accessory as claimed in any preceding claim, wherein the first
and second seals are elastic seals and are in mutual contact
9. A safety needle accessory as claimed in any preceding claim, wherein the first
and second seals are elastic seals and comprise a unitary structure.
10. A safety needle accessory as claimed in any preceding claim, wherein the first
and/or second seals are elastic seals and are co-injection moulded on to the hub.
11. A safety needle accessory as claimed in any preceding claim, wherein the first
and/or second seals are composed of low-density polyethylene or a rubber.
12. A safety needle accessory as claimed in claim 1, wherein the first seal is an
adhesive.
13. A safety needle accessory as claimed in any preceding claim, wherein the pack
is substantially tubular.
14. A safety needle accessory as claimed in any preceding claim, wherein the
slidable sleeve has an elastically deformable portion and/or further comprises an
elastically deformable member such that as the slidable sleeve is caused to move in-
the first direction, a resultant force is generated in the deformable portion or
deformable member which causes the slidable sleeve to move in the second direction
when the needle is removed from a patient.
15. A safety needle accessory as claimed in any preceding claim, further
comprising a locking mechanism capable of retaining the slidable sleeve, in the third
position after removal of the needle from a patient.
16. A safety needle accessory as claimed in any preceding claim, the needle is
partially exposed in the first position.
17. An injection device comprising a syringe having a hollow needle attached
thereto and a safety needle accessory as claimed in any preceding claim.
18. An injection device as claimed in claim 17, wherein the syringe is pre-filled
with an injectable composition.
19. An injection device as claimed in claim 17, wherein the syringe is a pre-filled
reconstitution syringe containing a lyophilised drug.
20. An injection device as claimed in any of claims 17 to 19, wherein, prior to use,
the needle is partially exposed in the first position.
| Section | Controller | Decision Date |
|---|---|---|
| # | Name | Date |
|---|---|---|
| 1 | 6573- delnp-2007-GPA-(18-02-2009).pdf | 2009-02-18 |
| 1 | 6573-DELNP-2007-RELEVANT DOCUMENTS [19-09-2023(online)].pdf | 2023-09-19 |
| 2 | 6573- delnp-2007-Form-18-(18-02-2009).pdf | 2009-02-18 |
| 2 | 6573-DELNP-2007-RELEVANT DOCUMENTS [27-09-2022(online)].pdf | 2022-09-27 |
| 3 | abstract.jpg | 2011-08-21 |
| 3 | 6573-DELNP-2007-RELEVANT DOCUMENTS [30-09-2021(online)]-1.pdf | 2021-09-30 |
| 4 | 6575-delnp-2007-pct-308.pdf | 2011-08-21 |
| 4 | 6573-DELNP-2007-RELEVANT DOCUMENTS [30-09-2021(online)].pdf | 2021-09-30 |
| 5 | 6573-DELNP-2007-RELEVANT DOCUMENTS [27-09-2021(online)].pdf | 2021-09-27 |
| 5 | 6573-delnp-2007-pct-416.pdf | 2011-08-21 |
| 6 | 6573-DELNP-2007-RELEVANT DOCUMENTS [20-03-2020(online)].pdf | 2020-03-20 |
| 6 | 6573-delnp-2007-pct-409.pdf | 2011-08-21 |
| 7 | 6573-DELNP-2007-RELEVANT DOCUMENTS [18-02-2020(online)].pdf | 2020-02-18 |
| 7 | 6573-delnp-2007-pct-402.pdf | 2011-08-21 |
| 8 | 6573-DELNP-2007-RELEVANT DOCUMENTS [30-03-2019(online)].pdf | 2019-03-30 |
| 8 | 6573-delnp-2007-pct-401.pdf | 2011-08-21 |
| 9 | 6573-delnp-2007-pct-304.pdf | 2011-08-21 |
| 9 | 6573-DELNP-2007-RELEVANT DOCUMENTS [15-03-2019(online)].pdf | 2019-03-15 |
| 10 | 6573-delnp-2007-pct-237.pdf | 2011-08-21 |
| 10 | 6573-DELNP-2007-RELEVANT DOCUMENTS [31-03-2018(online)].pdf | 2018-03-31 |
| 11 | 6573-delnp-2007-pct-220.pdf | 2011-08-21 |
| 11 | 6573-DELNP-2007-RELEVANT DOCUMENTS [21-03-2018(online)].pdf | 2018-03-21 |
| 12 | 6573-DELNP-2007-Correspondence-060916.pdf | 2016-09-08 |
| 12 | 6573-delnp-2007-pct-210.pdf | 2011-08-21 |
| 13 | 6573-delnp-2007-pct-101.pdf | 2011-08-21 |
| 13 | 6573-DELNP-2007-Power of Attorney-060916.pdf | 2016-09-08 |
| 14 | 6573-delnp-2007-form-5.pdf | 2011-08-21 |
| 14 | Description(Complete) [02-09-2016(online)].pdf | 2016-09-02 |
| 15 | 6573-delnp-2007-form-3.pdf | 2011-08-21 |
| 15 | Form 13 [02-09-2016(online)].pdf | 2016-09-02 |
| 16 | 6573-delnp-2007-form-2.pdf | 2011-08-21 |
| 16 | Form 26 [02-09-2016(online)].pdf | 2016-09-02 |
| 17 | Marked Copy [02-09-2016(online)].pdf | 2016-09-02 |
| 17 | 6573-delnp-2007-form-1.pdf | 2011-08-21 |
| 18 | 6573-delnp-2007-drawings.pdf | 2011-08-21 |
| 18 | Other Patent Document [02-09-2016(online)].pdf | 2016-09-02 |
| 19 | 6573-delnp-2007-description (complete).pdf | 2011-08-21 |
| 19 | Petition Under Rule 137 [02-09-2016(online)].pdf | 2016-09-02 |
| 20 | 6573-delnp-2007-correspondence-others.pdf | 2011-08-21 |
| 20 | 6573-DELNP-2007_EXAMREPORT.pdf | 2016-06-30 |
| 21 | 6573-delnp-2007-claims.pdf | 2011-08-21 |
| 21 | 6573-delnp-2007-Correspondence Others-(27-04-2015).pdf | 2015-04-27 |
| 22 | 6573-delnp-2007-abstract.pdf | 2011-08-21 |
| 22 | 6573-delnp-2007-Form-3-(27-04-2015).pdf | 2015-04-27 |
| 23 | 6573 Specification.pdf | 2015-03-20 |
| 23 | 6573-delnp-2007-Assignment-(30-03-2015).pdf | 2015-03-30 |
| 24 | 6573-delnp-2007-Correspondence Others-(30-03-2015).pdf | 2015-03-30 |
| 24 | 6573 RESPONSE.pdf | 2015-03-20 |
| 25 | 6573 Others.pdf | 2015-03-20 |
| 25 | 6573-delnp-2007-GPA-(30-03-2015).pdf | 2015-03-30 |
| 26 | 6573 Abstract.pdf | 2015-03-20 |
| 26 | 6573 amended claims.pdf | 2015-03-20 |
| 27 | 6573 Abstract.pdf | 2015-03-20 |
| 27 | 6573 amended claims.pdf | 2015-03-20 |
| 28 | 6573 Others.pdf | 2015-03-20 |
| 28 | 6573-delnp-2007-GPA-(30-03-2015).pdf | 2015-03-30 |
| 29 | 6573 RESPONSE.pdf | 2015-03-20 |
| 29 | 6573-delnp-2007-Correspondence Others-(30-03-2015).pdf | 2015-03-30 |
| 30 | 6573 Specification.pdf | 2015-03-20 |
| 30 | 6573-delnp-2007-Assignment-(30-03-2015).pdf | 2015-03-30 |
| 31 | 6573-delnp-2007-abstract.pdf | 2011-08-21 |
| 31 | 6573-delnp-2007-Form-3-(27-04-2015).pdf | 2015-04-27 |
| 32 | 6573-delnp-2007-claims.pdf | 2011-08-21 |
| 32 | 6573-delnp-2007-Correspondence Others-(27-04-2015).pdf | 2015-04-27 |
| 33 | 6573-delnp-2007-correspondence-others.pdf | 2011-08-21 |
| 33 | 6573-DELNP-2007_EXAMREPORT.pdf | 2016-06-30 |
| 34 | 6573-delnp-2007-description (complete).pdf | 2011-08-21 |
| 34 | Petition Under Rule 137 [02-09-2016(online)].pdf | 2016-09-02 |
| 35 | 6573-delnp-2007-drawings.pdf | 2011-08-21 |
| 35 | Other Patent Document [02-09-2016(online)].pdf | 2016-09-02 |
| 36 | Marked Copy [02-09-2016(online)].pdf | 2016-09-02 |
| 36 | 6573-delnp-2007-form-1.pdf | 2011-08-21 |
| 37 | 6573-delnp-2007-form-2.pdf | 2011-08-21 |
| 37 | Form 26 [02-09-2016(online)].pdf | 2016-09-02 |
| 38 | 6573-delnp-2007-form-3.pdf | 2011-08-21 |
| 38 | Form 13 [02-09-2016(online)].pdf | 2016-09-02 |
| 39 | 6573-delnp-2007-form-5.pdf | 2011-08-21 |
| 39 | Description(Complete) [02-09-2016(online)].pdf | 2016-09-02 |
| 40 | 6573-delnp-2007-pct-101.pdf | 2011-08-21 |
| 40 | 6573-DELNP-2007-Power of Attorney-060916.pdf | 2016-09-08 |
| 41 | 6573-DELNP-2007-Correspondence-060916.pdf | 2016-09-08 |
| 41 | 6573-delnp-2007-pct-210.pdf | 2011-08-21 |
| 42 | 6573-delnp-2007-pct-220.pdf | 2011-08-21 |
| 42 | 6573-DELNP-2007-RELEVANT DOCUMENTS [21-03-2018(online)].pdf | 2018-03-21 |
| 43 | 6573-delnp-2007-pct-237.pdf | 2011-08-21 |
| 43 | 6573-DELNP-2007-RELEVANT DOCUMENTS [31-03-2018(online)].pdf | 2018-03-31 |
| 44 | 6573-delnp-2007-pct-304.pdf | 2011-08-21 |
| 44 | 6573-DELNP-2007-RELEVANT DOCUMENTS [15-03-2019(online)].pdf | 2019-03-15 |
| 45 | 6573-delnp-2007-pct-401.pdf | 2011-08-21 |
| 45 | 6573-DELNP-2007-RELEVANT DOCUMENTS [30-03-2019(online)].pdf | 2019-03-30 |
| 46 | 6573-DELNP-2007-RELEVANT DOCUMENTS [18-02-2020(online)].pdf | 2020-02-18 |
| 46 | 6573-delnp-2007-pct-402.pdf | 2011-08-21 |
| 47 | 6573-DELNP-2007-RELEVANT DOCUMENTS [20-03-2020(online)].pdf | 2020-03-20 |
| 47 | 6573-delnp-2007-pct-409.pdf | 2011-08-21 |
| 48 | 6573-DELNP-2007-RELEVANT DOCUMENTS [27-09-2021(online)].pdf | 2021-09-27 |
| 48 | 6573-delnp-2007-pct-416.pdf | 2011-08-21 |
| 49 | 6575-delnp-2007-pct-308.pdf | 2011-08-21 |
| 49 | 6573-DELNP-2007-RELEVANT DOCUMENTS [30-09-2021(online)].pdf | 2021-09-30 |
| 50 | abstract.jpg | 2011-08-21 |
| 50 | 6573-DELNP-2007-RELEVANT DOCUMENTS [30-09-2021(online)]-1.pdf | 2021-09-30 |
| 51 | 6573- delnp-2007-Form-18-(18-02-2009).pdf | 2009-02-18 |
| 51 | 6573-DELNP-2007-RELEVANT DOCUMENTS [27-09-2022(online)].pdf | 2022-09-27 |
| 52 | 6573- delnp-2007-GPA-(18-02-2009).pdf | 2009-02-18 |
| 52 | 6573-DELNP-2007-RELEVANT DOCUMENTS [19-09-2023(online)].pdf | 2023-09-19 |